Association between HTLV-I Infection and Chronic Lupoid Leishmaniasis | ||
Iranian Journal of Basic Medical Sciences | ||
مقاله 20، دوره 16، شماره 3، خرداد 2013، صفحه 281-283 اصل مقاله (1.34 M) | ||
شناسه دیجیتال (DOI): 10.22038/ijbms.2013.748 | ||
نویسندگان | ||
Fakhrozaman Pezeshkpoor1؛ Seyed Abdol Rahim Rezaei2؛ Abbas Shirdel3؛ Mohammad Khajedaluee4؛ Mansoreh Alizadeh1؛ Mohammad Javad Yazdanpanah* 1 | ||
1Cutaneous Leishmanaisis Research Center,Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
2HTLV-I Foundation, Immunology Department, Mashhad University of Medical Sciences, Mashhad, Iran | ||
3Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
4Department of Social Medicine, Mashhad University of Medical Sciences, Mashhad, Iran | ||
کلیدواژهها | ||
Cutaneous lupoid leishmaniasis Cutaneous leishmaniasis Human T cell lymphotropic virus type I | ||
مراجع | ||
Lupi O. Protozoa and worms. In: Bolognia JL, Jorizzo JL, Rapini RO, Schaffer JV, editors. Dermatology. 2th ed. Spain: Mosby Elsevier; 2008. Vol 1.p.1263-1290. 2. Oumeish OY. Cutaneous leishmaniasis: a historical perspective. Clin Dermatol 1999 ;17:249-254. 3. Asilian A, Iraji F, Hedaiti HR, Siadat AH, Enshaieh S. Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): a case series of 24 patients. Dermatol Online J 2006; 12:3. 4. Vega Lopez F, Hay RJ. Parasitic worms and protozoa. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s text book of dermatology. 8 th ed.USA: Blackwell Science; 2010. Vol 2 p.37.1-44. 5. Ajdary S, Alimohammadian MH, Eslami MB, Kemp K, Kharazmi A. Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 2000; 68:1760- 1764. 6. Stefanidou MP, Antoniou M, Koutsopoulos AV, Neofytou YT, Krasagakis K, Kruger-Krasagakis S, et al. A rare case of leishmaniasisrecidivacutis evolving for 31 years caused by Leishmaniatropica.
Int J Dermatol 2008; 47:588-589.
7. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F,
Bidkhori HR, Shamsian SK, Ahmadi S,
et al . High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based
seroepidemiologysurvey. J Clin Virol 2011; 52:172-176.
8. Nakada K, Yamaguchi K, Furugen S, Nakasone T, Nakasone K, Oshiro
Y,
et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer 1987; 40:145-148.
9. Goncalves DU, Guedes AC, Proietti AB, Martins ML, Proietti FA,
Lambertucci JR,
et al. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus
type-1. Am J Trop Med Hyg 2003; 68:562-565.
10. Lenzi ME, Cuzzi-Maya T, Oliveira AL, Andrada-Serpa MJ, Araujo AQ.
Dermatological findings of human T lymphotropic virus type 1
(HTLV-I)-associated myelopathy/tropical spastic paraparesis.
Clin Infect Dis 2003; 36:507-513.
283 HTLV-I Infection and Chronic Lupoid Leishmaniasis Pezeshkpoor F et al Iran J Basic Med Sci; Vol. 16, No. 3, Mar 2013 11. Kuroda Y, Takashima H. Impairment of cell –mediated immune response in HTLV-I associated myelopathy. J Neurol Sci 1990; 100:211-216. 12. Lenis AM, Blank A, Valderrama L, Saravia NG. Relationship between the human T-lymphotropic virus type 1 infection and clinical manifestations of tegumentary leishmaniasis in the Colombian Pacific Coast. Mem Inst Oswaldo Cruz 1999; 94:19-20. 13. Meymandi S, Dabiri S, Shamsi-Meymandi M, Nikpour H, Kharazmi A. Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis. Arch Iran Med 2009; 12:371-376. | ||
آمار تعداد مشاهده مقاله: 2,127 تعداد دریافت فایل اصل مقاله: 1,400 |